• Access the event and schedule of presenting companies at virtualinvestorco.com 
• Live video webcast roundtable discussions with members of Management and Thought Leaders across participating companies 

 JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today announced it will host the Virtual Investor Roundtable Event November 16-18, 2021. As part of the virtual event, JTC partnered companies will provide a brief introduction, followed by a moderated Roundtable discussion and an interactive Q&A session.

In addition to the moderated portion of the event, all investors and interested parties will have the opportunity to submit questions live during the event. Interested parties may also pre-submit questions in advance of the live event, which can be sent via the conference website at virtualinvestorco.com. Participating companies will answer as many questions as possible during the event.

The schedule for the Virtual Investor Roundtable event is as follows:

Tuesday, November 16, 2021

• 9:00 AM ET: Outlook Therapeutics, Inc. (Nasdaq:OTLK) - Webcast
• 11:00 AM ET: Cyclo Therapeutics, Inc. (Nasdaq:CYTH) - Webcast
• 1:00 PM ET: enVVeno Medical Corporation (Nasdaq:NVNO) - Webcast
• 3:00 PM ET: SinglePoint, Inc. (OTCQB:SING) - Webcast

Wednesday, November 17, 2021

• 9:00 AM ET: American Resources Corporation (Nasdaq:AREC) - Webcast
• 11:00 AM ET: Ceapro, Inc. (TSX-V:CZO; OTCQX:CRPOF) - Webcast
• 1:00 PM ET: Novan, Inc. (Nasdaq:NOVN) - Webcast
• 3:00 PM ET: iTolerance, Inc. (Private) - Webcast

Thursday, November 18, 2021

• 9:00 AM ET: CNS Pharmaceuticals Inc. (Nasdaq:CNSP) - Webcast
• 11:00 AM ET: Moleculin Biotech, Inc. (Nasdaq:MBRX) - Webcast
• 1:00 PM ET: Viewpoint Molecular Targeting (Private) - Webcast
• 3:00 PM ET: Vallon Pharmaceuticals, Inc. (Nasdaq:VLON) - Webcast

Investors and interested parties can access the event schedule and individual company webcast details at www.virtualinvestorco.com.

About JTC Team

JTC is a fully integrated corporate communications firm that is dedicated to helping you tell your story to the right audiences in order to build awareness. JTC has developed a reputation of excellence for executing on robust communication strategies that deliver results. The Company partners with both public and private companies across the Life Sciences and Technology industries to help raise awareness and build stakeholder value. For more information, please visit www.jtcir.com or connect with the company on Twitter and LinkedIn.

Contact:

Jenene Thomas
JTC Team, LLC
T: +1 (833) 475-8247
This email address is being protected from spambots. You need JavaScript enabled to view it.